Here's Why Pfizer Is Willing To Pay $500 Million For Novavax's Matrix-M

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
IEEE

Column-wise Quantization of Weights and Partial Sums for Accurate and Efficient Compute-In-Memory Accelerators

Abstract: Compute-in-memory (CIM) is an efficient method for implementing deep neural networks (DNNs) but suffers from substantial overhead from analog-to-digital converters (ADCs), especially as ADC ...